本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

NLS Pharmaceutics Ltd.

2.44
-0.1300-5.06%
盘后2.490.0500+2.05%16:39 EDT
成交量:11.02万
成交额:26.99万
市值:877.81万
市盈率:-0.37
高:2.59
开:2.55
低:2.34
收:2.57
数据加载中...
2025/07/01

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/06/16

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/06/06

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/05/16

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/04/15

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/03/31

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/03/10

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/02/25

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/02/10

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/01/31

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/01/28

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/01/16

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/01/08

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2024/12/30

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2024/12/19

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2024/12/11

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2024/11/25

SEC问询函

Form CORRESP - Correspondence
2024/11/21

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/18

SEC问询函

Form CORRESP - Correspondence
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]